Delivery of Pfizer jabs will be reduced by 10% to Osaka, Setagaya to Tokyo, more
The government will reduce the supply of Pfizer’s COVID-19 vaccine to local governments by 10% for the first half of August if they are deemed to have excess stock.
Taro Kono, the minister of administrative reform who is in charge of the deployment of the COVID-19 vaccine, on July 13 revealed the change in the government plan for the distribution of vaccine doses, jointly developed by the American pharmaceutical company Pfizer Inc. and its German partner, BioNTech.
Under the new plan, the central government will reduce the shipment of some 350,000 doses of Pfizer vaccine to municipalities such as Sapporo, Sendai, Nagoya, Osaka and Kita-Kyushu as well as the Setagaya, Ota and Adachi districts of Tokyo. , according to the Ministry of Health.
The central government had previously said it would ship about 11.7 million doses of Pfizer vaccine every two weeks in August and September and distribute 80 percent of the doses, or about 9.36 million, as a “baseline supply” to people. prefectural governments in proportion to their populations.
The central government had also indicated that Pfizer’s shipments would be reduced by 10 percent for local governments that have more than six weeks of excess stock, as shown by its Vaccination Record System (VRS).
To the 350,000 doses of Pfizer that the central government will stop providing to local communities in overstock will be added to the 1.755 million doses classified as “adjustment supplies” for the prefectural communities.
Each prefectural government will allocate regularization supplies to the communes.
The central government said it is currently preparing to allow prefectural governments access to the VRS to facilitate smooth distribution and share hit count and other data from July 15.
However, the RSV has proven ineffective in revealing the stock of vaccine doses in real time, due to delays at the municipal level in entering immunization data into the system in some cases.
Kono called on municipalities to quickly enter data on the VRS. But the central government will likely face a backlash from those targeted for a reduction in vaccine supply under the new distribution plan.